James L. Tyree, Director at ChemoCentryx, Inc. (CCXI), sold 7,667 shares at $25.65 ($197K) on 2022-06-09, disclosed to the SEC on 2022-06-13.
Open-market sale of $197k CCXI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.65 | 3,804 | $98K | 49.6% |
| 2 | $25.65 | 3,804 | $98K | 49.6% |
| 3 | $26.22 | 59 | $2K | 0.8% |
| Total | $25.65 avg | 7,667 | $197K | 100% |
| Filing → |
| ASRT | SELL | 2024-03-15 | $11K | — | Filing → |
| GNLX | SELL | 2023-12-14 | $192K | — | Filing → |
| ASRT | SELL | 2023-05-05 | $259K | — | Filing → |